Serum Markers of Brain Injury in Pediatric Patients with Congenital Heart Defects Undergoing Cardiac Surgery: Diagnostic and Prognostic Role

<b>Introduction</b>: The objectives of this study were to assess the role of neuromarkers like glial fibrillary acidic protein (GFAP), brain-derived neurotrophic factor (BDNF), protein S100 (pS100), and neuron-specific enolase (NSE) as diagnostic markers of acute brain injury and also as...

Full description

Bibliographic Details
Main Authors: Lacramioara Eliza Chiperi, Adina Huţanu, Cristina Tecar, Iolanda Muntean
Format: Article
Language:English
Published: MDPI AG 2023-10-01
Series:Clinics and Practice
Subjects:
Online Access:https://www.mdpi.com/2039-7283/13/5/113
_version_ 1797574191381217280
author Lacramioara Eliza Chiperi
Adina Huţanu
Cristina Tecar
Iolanda Muntean
author_facet Lacramioara Eliza Chiperi
Adina Huţanu
Cristina Tecar
Iolanda Muntean
author_sort Lacramioara Eliza Chiperi
collection DOAJ
description <b>Introduction</b>: The objectives of this study were to assess the role of neuromarkers like glial fibrillary acidic protein (GFAP), brain-derived neurotrophic factor (BDNF), protein S100 (pS100), and neuron-specific enolase (NSE) as diagnostic markers of acute brain injury and also as prognostic markers for short-term neurodevelopmental impairment. <b>Methods</b>: Pediatric patients with congenital heart defects (CHDs) undergoing elective cardiac surgery were included. Neurodevelopmental functioning was assessed preoperatively and 4–6 months postoperatively using the Denver Developmental Screening Test II. Blood samples were collected preoperatively and postoperatively. During surgery, regional cerebral tissue oxygen saturation was monitored using near-infrared spectroscopy (NIRS). <b>Results</b>: Forty-two patients were enrolled and dichotomized into cyanotic and non-cyanotic groups based on peripheric oxygen saturation. Nineteen patients (65.5%) had abnormal developmental scores in the non-cyanotic group and eleven (84.6%) in the cyanotic group. A good diagnostic model was observed between NIRS values and GFAP in the cyanotic CHD group (AUC = 0.7). A good predicting model was observed with GFAP and developmental scores in the cyanotic CHD group (AUC = 0.667). A correlation was found between NSE and developmental quotient scores (r = 0.09, <i>p</i> = 0.046). <b>Conclusions</b>: From all four neuromarkers studied, only GFAP was demonstrated to be a good diagnostic and prognostic factor in cyanotic CHD patients. NSE had only prognostic value.
first_indexed 2024-03-10T21:20:25Z
format Article
id doaj.art-2b476b30d9ce45a1a34857fa2572fda8
institution Directory Open Access Journal
issn 2039-7283
language English
last_indexed 2024-03-10T21:20:25Z
publishDate 2023-10-01
publisher MDPI AG
record_format Article
series Clinics and Practice
spelling doaj.art-2b476b30d9ce45a1a34857fa2572fda82023-11-19T16:07:31ZengMDPI AGClinics and Practice2039-72832023-10-011351253126510.3390/clinpract13050113Serum Markers of Brain Injury in Pediatric Patients with Congenital Heart Defects Undergoing Cardiac Surgery: Diagnostic and Prognostic RoleLacramioara Eliza Chiperi0Adina Huţanu1Cristina Tecar2Iolanda Muntean3Clinic of Pediatric Cardiology, Emergency Institute for Cardiovascular Diseases and Heart Transplant, 540136 Targu Mures, RomaniaDepartment of Laboratory Medicine, George Emil Palade University of Medicine, Pharmacy, Sciences and Technology of Targu Mures, 540142 Targu Mures, RomaniaDepartment of Neurosciences, Iuliu Hatieganu University of Medicine and Pharmacy, 400129 Cluj-Napoca, RomaniaClinic of Pediatric Cardiology, Emergency Institute for Cardiovascular Diseases and Heart Transplant, George Emil Palade University of Medicine, Pharmacy, Sciences and Technology of Targu Mures, 540142 Targu Mures, Romania<b>Introduction</b>: The objectives of this study were to assess the role of neuromarkers like glial fibrillary acidic protein (GFAP), brain-derived neurotrophic factor (BDNF), protein S100 (pS100), and neuron-specific enolase (NSE) as diagnostic markers of acute brain injury and also as prognostic markers for short-term neurodevelopmental impairment. <b>Methods</b>: Pediatric patients with congenital heart defects (CHDs) undergoing elective cardiac surgery were included. Neurodevelopmental functioning was assessed preoperatively and 4–6 months postoperatively using the Denver Developmental Screening Test II. Blood samples were collected preoperatively and postoperatively. During surgery, regional cerebral tissue oxygen saturation was monitored using near-infrared spectroscopy (NIRS). <b>Results</b>: Forty-two patients were enrolled and dichotomized into cyanotic and non-cyanotic groups based on peripheric oxygen saturation. Nineteen patients (65.5%) had abnormal developmental scores in the non-cyanotic group and eleven (84.6%) in the cyanotic group. A good diagnostic model was observed between NIRS values and GFAP in the cyanotic CHD group (AUC = 0.7). A good predicting model was observed with GFAP and developmental scores in the cyanotic CHD group (AUC = 0.667). A correlation was found between NSE and developmental quotient scores (r = 0.09, <i>p</i> = 0.046). <b>Conclusions</b>: From all four neuromarkers studied, only GFAP was demonstrated to be a good diagnostic and prognostic factor in cyanotic CHD patients. NSE had only prognostic value.https://www.mdpi.com/2039-7283/13/5/113congenital heart defectneuromarkerheart surgeryglial fibrillary acidic proteinbrain-derived neurotrophic factorprotein S100
spellingShingle Lacramioara Eliza Chiperi
Adina Huţanu
Cristina Tecar
Iolanda Muntean
Serum Markers of Brain Injury in Pediatric Patients with Congenital Heart Defects Undergoing Cardiac Surgery: Diagnostic and Prognostic Role
Clinics and Practice
congenital heart defect
neuromarker
heart surgery
glial fibrillary acidic protein
brain-derived neurotrophic factor
protein S100
title Serum Markers of Brain Injury in Pediatric Patients with Congenital Heart Defects Undergoing Cardiac Surgery: Diagnostic and Prognostic Role
title_full Serum Markers of Brain Injury in Pediatric Patients with Congenital Heart Defects Undergoing Cardiac Surgery: Diagnostic and Prognostic Role
title_fullStr Serum Markers of Brain Injury in Pediatric Patients with Congenital Heart Defects Undergoing Cardiac Surgery: Diagnostic and Prognostic Role
title_full_unstemmed Serum Markers of Brain Injury in Pediatric Patients with Congenital Heart Defects Undergoing Cardiac Surgery: Diagnostic and Prognostic Role
title_short Serum Markers of Brain Injury in Pediatric Patients with Congenital Heart Defects Undergoing Cardiac Surgery: Diagnostic and Prognostic Role
title_sort serum markers of brain injury in pediatric patients with congenital heart defects undergoing cardiac surgery diagnostic and prognostic role
topic congenital heart defect
neuromarker
heart surgery
glial fibrillary acidic protein
brain-derived neurotrophic factor
protein S100
url https://www.mdpi.com/2039-7283/13/5/113
work_keys_str_mv AT lacramioaraelizachiperi serummarkersofbraininjuryinpediatricpatientswithcongenitalheartdefectsundergoingcardiacsurgerydiagnosticandprognosticrole
AT adinahutanu serummarkersofbraininjuryinpediatricpatientswithcongenitalheartdefectsundergoingcardiacsurgerydiagnosticandprognosticrole
AT cristinatecar serummarkersofbraininjuryinpediatricpatientswithcongenitalheartdefectsundergoingcardiacsurgerydiagnosticandprognosticrole
AT iolandamuntean serummarkersofbraininjuryinpediatricpatientswithcongenitalheartdefectsundergoingcardiacsurgerydiagnosticandprognosticrole